Shestakova Lydia N, Lyubova Tatyana S, Lermontova Svetlana A, Belotelov Artem O, Peskova Nina N, Klapshina Larisa G, Balalaeva Irina V, Shilyagina Natalia Y
Institute of Biology and Biomedicine, Lobachevsky State University, Gagarin Ave., 23, 603950 Nizhny Novgorod, Russia.
Razuvaev Institute of Organomettalic Chemistry, Russian Academy of Sciences, St. Tropinina, 49, 603137 Nizhny Novgorod, Russia.
Pharmaceutics. 2022 Nov 30;14(12):2655. doi: 10.3390/pharmaceutics14122655.
Photodynamic therapy (PDT) is a rapidly developing modality of primary and adjuvant anticancer treatment. The main trends today are the search for new effective photodynamic agents and the creation of targeted delivery systems with the function of controlling the release of the agent in the tumor. Recently, the new group of cyanoarylporphyrazine dyes was reported, which combine the properties of photosensitizers and sensors of the local microenvironment. Such unique characteristics allow the release of the photosensitizer from the transport carrier to be assessed in real time in vivo. The aim of the present work was to compare the photophysical and photobiological properties of tetra(2-naphthyl)tetracyanoporphyrazine and its newly synthesized Fe(II) complex. We have shown that the chelation of the Fe(II) cation with the porphyrazine macrocycle leads to a decrease in molar extinction and an increase in the quantum yield of fluorescence and photostability. We demonstrate that the iron cation significantly affects the rate of dye accumulation in cells, the dark toxicity and photodynamic activity, and the direction of the changes depends on the particular cell line. However, in all the cases, the photodynamic index of a metal complex was higher than that of a metal-free base. In general, both of the compounds were found to be very promising for PDT, including for the use with transport delivery systems, and can be recommended for further in vivo studies.
光动力疗法(PDT)是一种快速发展的原发性和辅助性抗癌治疗方式。当今的主要趋势是寻找新的有效光动力剂以及创建具有控制药物在肿瘤中释放功能的靶向递送系统。最近,报道了一类新的氰基芳基卟啉嗪染料,它们兼具光敏剂和局部微环境传感器的特性。这种独特的特性使得能够在体内实时评估光敏剂从运输载体中的释放情况。本研究的目的是比较四(2-萘基)四氰基卟啉嗪及其新合成的铁(II)配合物的光物理和光生物学性质。我们已经表明,铁(II)阳离子与卟啉嗪大环的螯合导致摩尔消光系数降低,荧光量子产率和光稳定性增加。我们证明铁阳离子显著影响染料在细胞中的积累速率、暗毒性和光动力活性,并且变化方向取决于特定的细胞系。然而,在所有情况下,金属配合物的光动力指数都高于无金属碱。总体而言,发现这两种化合物对于光动力疗法都非常有前景,包括与运输递送系统一起使用,并且可以推荐用于进一步的体内研究。
Biophys Rev. 2023-9-25
Biochim Biophys Acta Gen Subj. 2017-9-13
Photochem Photobiol Sci. 2019-10-18
J Biophotonics. 2020-1
Chem Sci. 2022-4-1
Nanomaterials (Basel). 2021-8-3
Photodiagnosis Photodyn Ther. 2021-6
Trends Cancer. 2021-6
Nanotechnology. 2021-5-7